Advertisement

Topics

New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points

07:00 EDT 7 Aug 2017 | Xconomy

San Antonio — Rapamycin Holdings has a new CEO, is raising a $3.5 million Series B round of funding, and plans to submit an investigational new drug filing to the FDA this year. If all goes well, the small biotech may start its first in-human clinical trials as early as later this year. “The company is […]

Original Article: New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points

NEXT ARTICLE

More From BioPortfolio on "New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...